1. Management of Double-Refractory Multiple Myeloma

   • Jason P. Meadows
   • Tomer M. Mark

   Multiple Myeloma (R Niesvizky, Section Editor) 23 August 2013 Pages: 253 - 260

2. Incorporating Novel Agents in the Management of Elderly Myeloma Patients

   • Tommasina Guglielmelli
   • Antonio Palumbo

   Multiple Myeloma (R Niesvizky, Section Editor) 29 September 2013 Pages: 261 - 269

3. New Approaches to Smoldering Myeloma

   • María-Victoria Mateos
   • Jesús F. San Miguel

   Multiple Myeloma (R Niesvizky, Section Editor) 23 August 2013 Pages: 270 - 276

4. Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy

   • Jordan Schecter
   • Suzanne Lentzsch

   Multiple Myeloma (R Niesvizky, Section Editor) 25 October 2013 Pages: 277 - 283

5. Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: What Place, If Any?

   • Sergio Giralt
   • Guenther Koehne

   Multiple Myeloma (R Niesvizky, Section Editor) 22 October 2013 Pages: 284 - 290

6. New Insights and Modern Treatment of AL Amyloidosis

   • Chakra P. Chaulagain
   • Raymond L. Comenzo

   Multiple Myeloma (R Niesvizky, Section Editor) 12 September 2013 Pages: 291 - 298

7. Genetic Basis of MPN: Beyond JAK2-V617F

   • Nicole C. C. Them
   • Robert Kralovics

   Myeloproliferative Disorders (JJ Kiladjian, Section Editor) 05 November 2013 Pages: 299 - 306

   

8. Are MPNs Vascular Diseases?

   • Guido Finazzi
   • Valerio De Stefano
   • Tiziano Barbui

   Myeloproliferative Disorders (JJ Kiladjian, Section Editor) 15 September 2013 Pages: 307 - 316

   

9. Preclinical Models for Drug Selection in Myeloproliferative Neoplasms

   • Niccolò Bartalucci
   • Costanza Bogani
   • Alessandro M. Vannucchi

   Myeloproliferative Disorders (JJ Kiladjian, Section Editor) 22 October 2013 Pages: 317 - 324

10. The New Landscape of Therapy for Myelofibrosis

    • Krisstina Gowin
    • Robyn Emanuel
    • Ruben A. Mesa

    Myeloproliferative Disorders (JJ Kiladjian, Section Editor) 08 October 2013 Pages: 325 - 332

    

11. WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update

    • Hans Michael Kvasnicka

    Myeloproliferative Disorders (JJ Kiladjian, Section Editor) 22 October 2013 Pages: 333 - 341

12. Molecular Classification of Myeloproliferative Neoplasms—Pros and Cons

    • Moosa Qureshi
    • Claire Harrison

    Myeloproliferative Disorders (JJ Kiladjian, Section Editor) 04 October 2013 Pages: 342 - 350

    

13. There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes

    • Amer M. Zeidan
    • Rami S. Komrokji

    Myelodysplastic Syndromes (M Sekeres, Section Editor) 25 August 2013 Pages: 351 - 360

14. Standardizing the Initial Evaluation for Myelodysplastic Syndromes

    • Danielle Marshall
    • Gail J. Roboz

    Myelodysplastic Syndromes (M Sekeres, Section Editor) 01 November 2013 Pages: 361 - 369

    

15. Febrile Neutropenia in Hematologic Malignancies

    • Michael K. Keng
    • Mikkael A. Sekeres

    Myelodysplastic Syndromes (M Sekeres, Section Editor) 29 August 2013 Pages: 370 - 378

16. When to Transplant MDS, and What to Do When Transplant Fails

    • Katja Sockel
    • Uwe Platzbecker

    Myelodysplastic Syndromes (M Sekeres, Section Editor) 04 October 2013 Pages: 379 - 385